• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Eliglustat tartrate, miglustat, imiglucerase, velaglucerase or a combination of these for the treatment of Gaucher disease: a review of clinical effectiveness and safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-stress testing for pregnant adults with diabetes
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dressing for patients undergoing hip or knee arthroplasty: clinical effectiveness and cost-effectiveness
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drug eluting stents. What should be the indications for their use at the MUHC?
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac output monitors to assess patient resuscitation needs: a review of clinical effectiveness and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel, Prasugrel and Ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines in adults with ADHD
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary medication review in long term care: a review of the clinical evidence and guidelines
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Aortic valve bypass (apicoaortic conduit) in adult degenerative aortic stenosis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Comparative effectiveness of rosuvastatin versus other statins: a review of clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Metabolic monitoring and interventions for reducing metabolic syndrome in patients treated with atypical antipsychotics: a review of the clinical evidence
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as diagnostic and therapeutic tools for pain of the cervical and lumbar spine: a review of clinical and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Bisphosphonates for the prevention of osteoporosis in patients treated with systematic corticosteroids: a review of the clinical evidence and guidelines
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Computed tomography and its carcinogenic effects in children and youth in Québec]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Management and patient safety of IVIG administration: a review of clinical practice guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) T-score as a measurement to assess the 10-year fracture risk: a review of the clinical evidence
2011     HTA Unit, University of Calgary Health technology reassessment and reinvestment: a systematic review of current practices
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Pediatric supraglottic airway devices: a review of clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Adrenal suppression and clinical harms by inhaled corticosteroids: a review of safety and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Robotic surgery versus open-chest surgery for internal mammary artery harvesting and mitral valve surgery: clinical effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Acetylsalicylic acid for venous thromboembolism prophylaxis: a review of clinical evidence, benefits and harms
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Feeding tube verification procedures: optimal timing and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Phallometric assessment of sex offenders: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-adherent versus traditional dressings for wound care: comparative effectiveness, safety, and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Suboxone for short-term detoxification: a review of the clinical evidence
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous insulin infusions in labouring women: guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination Benzodiazepine-Opioid use: a review of the evidence on safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of fentanyl and continuous electronic fetal monitoring in labour and delivery: a review of clinical effectiveness, safety, and clinical practice guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Enzyme replacement therapy for rare diseases: a review of clinical efficacy
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiviral stockpiling strategies for pandemic influenza: a review of the clinical and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological and non-pharmacological therapies for adults with attention-deficit/hyperactivity disorder: systematic review and meta-analysis of clinical evidence
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as diagnostic and therapeutic tools for pain of the cervical and lumbar spine: a review of clinical and cost-effectiveness
2011     Medical Advisory Secretariat (MAS) Corneal collagen cross-linking using riboflavin and ultraviolet-A for corneal thinning disorders
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Long versus short acting drugs for attention deficit/hyperactivity disorder in children and adolescents: a review of the guidelines and recommendations
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Education classes for diabetes management: a review of the comparative clinical and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electrical Stimulation (FES) for children with spinal cord injuries: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Glyburide, gliclazide or glimepiride in the elderly with type 2 diabetes: a review of the clinical effectiveness and safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiplatelet agents for acute coronary syndrome: a review of the guidelines and recommendations
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Calibration of blood glucose monitors for diabetes: a review of the clinical evidence and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Amisulpride for adults with refractory schizophrenia: a review of the clinical effectiveness and safety
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) The association between obesity, aboriginal or indigenous people, indian or alaskan natives living in North America and residence in remote locations and severe outcomes with seasonal and pandemic influenza: a review of the clinical evidence
2011     Medical Advisory Secretariat (MAS) Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Preoperative skin antiseptic preparations and application techniques for preventing surgical site infections: a systematic review of the clinical evidence and guidelines
2011     Medical Advisory Secretariat (MAS) Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis
2011     Medical Advisory Secretariat (MAS) Constraint induced movement therapy for rehabilitation of arm dysfunction after stroke in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost-effectiveness analyses
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Fiducial markers for improving treatment margins in radiotherapy for prostate cancer
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the VerifyNow point of care test to detect nonresponsiveness to clopidogrel and aspirin
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of esophageal cancer: systematic review on surgical techniques]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Surgical treatment of esophageal cancer: effect of operative volume on clinical outcomes]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids as co-analgesics: review of clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure therapy for patients infected wounds: a review of the clinical and cost-effectiveness evidence and recommendations for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Patient lifts and transfer equipment: a review of clinical and cost-effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Chair alarms in residential care and acute care: a review of the clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Deep brain stimulation for parkinson's disease and neurological movement disorders: a review of the clinical and cost-effectiveness and guidelines
2010     Institute of Health Economics (IHE) Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bupropion for adults with attention deficit hyperactivity disorder: a review of the clinical effectiveness and harms of misuse
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of periodontal disease in patients with diabetes: a review of clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug therapy for prophylactic and post-exposure treatment of H1N1: a review of the comparative clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Lindane and other treatments for lice and scabies: a review of clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Varenicline for smoking cessation in patients with psychiatric illness: a review of the risks
2010     Medical Advisory Secretariat (MAS) Clinical utility of vitamin D testing: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Clinical utility of serologic testing for celiac disease in Ontario (symptomatic patients)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pain scales in acute care settings: a review of the accuracy and reliability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Prefabricated and custom made foot orthotics: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab for maintenance therapy for treatment of Crohn's disease: a review of the clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valves for valvular heart disease: an updated review of the clinical and cost-effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Albumin versus synthetic plasma volume expanders: a review of the clinical and cost-effectiveness and guidelines for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Weighted blankets and vests: safety, efficacy and issues related to their use in different intervention settings]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote ischemic conditioning: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Robot Assisted Radical Prostatectomy (RARP)]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive versus negative needleless connectors for central venous lines and peripheral lines: a review of the clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of bupropion in patients with depression and the associated risk of seizures: safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluconazole and pharmaceuticals without inactive ingredients for autism: a review of the clinical effectiveness
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Is there a place for home oxygen therapy in the management of obstructive sleep apnea?]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Gabapentin tablets versus capsules: a review of the evidence regarding appropriate use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Eden alternative and green house concept of care: review of clinical effectiveness, cost-effectiveness, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bifocal lenses under +0.50 diopter: a review of the clinical effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) KRAS testing for anti-EGFR therapy in advanced colorectal cancer : an evidence-based and economic analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening and post-operative monitoring in adult patients with obstructive sleep apnea: clinical effectiveness and guidelines